Astrana Health (ASTH) vs Booz Allen Hamilton (BAH)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Astrana Health (ASTH) has outperformed Booz Allen Hamilton (BAH) over the past year, gaining 22.5% versus a loss of 34.0%. Over five years, BAH leads with a -15.2% price change compared with -48.0% for ASTH. Booz Allen Hamilton is the larger company by market cap ($8.26 billion vs $1.84 billion), about 4.5 times the size.
On valuation, Booz Allen Hamilton trades at a lower forward P/E (10.2x vs 10.2x for Astrana Health). Booz Allen Hamilton pays a dividend yielding 3.32%, while Astrana Health does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ASTH | BAH |
|---|---|---|
| Share price | $37.14 | $68.69 |
| Market cap | $1.84B | $8.26B |
| 1-day change | +0.38% | +0.81% |
| YTD return | +49.70% | -18.58% |
| 1-year return | +22.45% | -33.98% |
| 5-year return | -48.05% | -15.17% |
| P/E ratio (TTM) | 44.75 | 10.72 |
| Forward P/E | 10.21 | 10.21 |
| EPS (TTM) | $0.83 | $6.41 |
| Dividend yield | 0.00% | 3.32% |
| Annual dividend | $0.00 | $2.28 |
| Revenue (latest FY) | — | $11.22B |
| Revenue growth (YoY) | — | -6.37% |
| Net income (latest FY) | — | $851.00M |
| Gross margin | — | 52.71% |
| Operating margin | — | 9.21% |
| Net margin | — | 7.59% |
| 52-week high | $51.60 | $109.10 |
| 52-week low | $18.08 | $59.50 |
| Distance from 52-week high | -28.02% | -37.04% |
| Analyst consensus | strong_buy | hold |
| Avg. price target upside | +39.12% | +22.84% |
| Average volume | 459.44K | 1.91M |
| Shares outstanding | 49.60M | 120.28M |
| Employees | 3,000 | 30,900 |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Industry | Professional Services | Professional Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Booz Allen Hamilton is about 4.5 times larger than Astrana Health by market value ($8.26B vs $1.84B).
- ASTH has outperformed BAH by 56.4 percentage points over the past year.
- Astrana Health trades at a higher earnings multiple (44.7x vs 10.7x trailing P/E).
- Booz Allen Hamilton offers a meaningfully higher dividend yield (3.32% vs 0.00%).
About Astrana Health
ASTH stock →Astrana Health, Inc., a healthcare management company, provides medical care services in the United States. The company operates through three segments: Care Partners, Care Delivery, and Care Enablement.
Consumer Discretionary · Professional Services · 3,000 employees
About Booz Allen Hamilton
BAH stock →Booz Allen Hamilton Holding Corporation, a technology company, provides technology solutions using artificial intelligence, cyber, and other technologies for government's cabinet-level departments and commercial customers in the United States and internationally. The company offers artificial intelligence (AI) which creates purpose-built AI solutions that adapt commercial and technology to the needs of the federal government; cyber solutions; and legacy systems with cloud-enabled infrastructure, data platforms, and software applications.It also provides multi-modal data fusion coupled with cyber and AI for intelligence, surveillance, and reconnaissance, earth observation, and domain awareness and battle management; and quantum information sciences that provides quantum computing, quantum sensing, quantum communications, post-quantum compute readiness, and post-quantum cryptography.
Consumer Discretionary · Professional Services · 30,900 employees
ASTH vs BAH FAQ
Which is bigger, Astrana Health or Booz Allen Hamilton?
Booz Allen Hamilton (BAH) is larger, with a market capitalization of $8.26B compared with $1.84B for Astrana Health (ASTH).
Which stock has performed better over the past year, ASTH or BAH?
ASTH returned +22.45% over the past 12 months, compared with -33.98% for BAH (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, ASTH or BAH?
BAH has the lower trailing P/E at 10.7, versus 44.7 for ASTH. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Astrana Health or Booz Allen Hamilton?
Booz Allen Hamilton pays a dividend yielding 3.32%, while Astrana Health does not currently pay a regular dividend.
Are Astrana Health and Booz Allen Hamilton in the same industry?
Yes. Both are classified in the Professional Services industry within the Consumer Discretionary sector.